BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 35903108)

  • 1. Sphingomyelin Depletion Inhibits CXCR4 Dynamics and CXCL12-Mediated Directed Cell Migration in Human T Cells.
    Gardeta SR; García-Cuesta EM; D'Agostino G; Soler Palacios B; Quijada-Freire A; Lucas P; Bernardino de la Serna J; Gonzalez-Riano C; Barbas C; Rodríguez-Frade JM; Mellado M
    Front Immunol; 2022; 13():925559. PubMed ID: 35903108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of cell migration by sphingomyelin synthases: sphingomyelin in lipid rafts decreases responsiveness to signaling by the CXCL12/CXCR4 pathway.
    Asano S; Kitatani K; Taniguchi M; Hashimoto M; Zama K; Mitsutake S; Igarashi Y; Takeya H; Kigawa J; Hayashi A; Umehara H; Okazaki T
    Mol Cell Biol; 2012 Aug; 32(16):3242-52. PubMed ID: 22688512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reciprocal regulation of CXCR4 and CXCR7 in intestinal mucosal homeostasis and inflammatory bowel disease.
    Werner L; Elad H; Brazowski E; Tulchinsky H; Vigodman S; Kopylov U; Halpern Z; Guzner-Gur H; Dotan I
    J Leukoc Biol; 2011 Sep; 90(3):583-90. PubMed ID: 21628333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Separating Actin-Dependent Chemokine Receptor Nanoclustering from Dimerization Indicates a Role for Clustering in CXCR4 Signaling and Function.
    Martínez-Muñoz L; Rodríguez-Frade JM; Barroso R; Sorzano CÓS; Torreño-Pina JA; Santiago CA; Manzo C; Lucas P; García-Cuesta EM; Gutierrez E; Barrio L; Vargas J; Cascio G; Carrasco YR; Sánchez-Madrid F; García-Parajo MF; Mellado M
    Mol Cell; 2018 Apr; 70(1):106-119.e10. PubMed ID: 29625032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Cytomegalovirus UL111A and US27 Gene Products Enhance the CXCL12/CXCR4 Signaling Axis via Distinct Mechanisms.
    Tu CC; Arnolds KL; O'Connor CM; Spencer JV
    J Virol; 2018 Mar; 92(5):. PubMed ID: 29237840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential regulation of CXCR4-mediated T-cell chemotaxis and mitogen-activated protein kinase activation by the membrane tyrosine phosphatase, CD45.
    Fernandis AZ; Cherla RP; Ganju RK
    J Biol Chem; 2003 Mar; 278(11):9536-43. PubMed ID: 12519755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CXCL12-CXCR4/CXCR7 Axis in Colorectal Cancer: Therapeutic Target in Preclinical and Clinical Studies.
    Khare T; Bissonnette M; Khare S
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting CXCL12/CXCR4 Axis in Tumor Immunotherapy.
    Zhou W; Guo S; Liu M; Burow ME; Wang G
    Curr Med Chem; 2019; 26(17):3026-3041. PubMed ID: 28875842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of chemokine CXCL12 and its receptor CXCR4 in folliculostellate (FS) cells of the rat anterior pituitary gland: the CXCL12/CXCR4 axis induces interconnection of FS cells.
    Horiguchi K; Ilmiawati C; Fujiwara K; Tsukada T; Kikuchi M; Yashiro T
    Endocrinology; 2012 Apr; 153(4):1717-24. PubMed ID: 22355073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of Wnt5A signaling is required for CXC chemokine ligand 12-mediated T-cell migration.
    Ghosh MC; Collins GD; Vandanmagsar B; Patel K; Brill M; Carter A; Lustig A; Becker KG; Wood WW; Emeche CD; French AD; O'Connell MP; Xu M; Weeraratna AT; Taub DD
    Blood; 2009 Aug; 114(7):1366-73. PubMed ID: 19520808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory CXCL12-CXCR4/CXCR7 axis mediates G-protein signaling pathway to influence the invasion and migration of nasopharyngeal carcinoma cells.
    Qiao N; Wang L; Wang T; Li H
    Tumour Biol; 2016 Jun; 37(6):8169-79. PubMed ID: 26715277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CXCL14 is a natural inhibitor of the CXCL12-CXCR4 signaling axis.
    Tanegashima K; Suzuki K; Nakayama Y; Tsuji K; Shigenaga A; Otaka A; Hara T
    FEBS Lett; 2013 Jun; 587(12):1731-5. PubMed ID: 23669361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A crosstalk between intracellular CXCR7 and CXCR4 involved in rapid CXCL12-triggered integrin activation but not in chemokine-triggered motility of human T lymphocytes and CD34+ cells.
    Hartmann TN; Grabovsky V; Pasvolsky R; Shulman Z; Buss EC; Spiegel A; Nagler A; Lapidot T; Thelen M; Alon R
    J Leukoc Biol; 2008 Oct; 84(4):1130-40. PubMed ID: 18653785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of chemokine (CXC motif) ligand 12/chemokine (CXC motif) receptor 4 axis (CXCL12/CXCR4)-mediated cell migration by targeting mammalian target of rapamycin (mTOR) pathway in human gastric carcinoma cells.
    Chen G; Chen SM; Wang X; Ding XF; Ding J; Meng LH
    J Biol Chem; 2012 Apr; 287(15):12132-41. PubMed ID: 22337890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synaptotagmin 3 deficiency in T cells impairs recycling of the chemokine receptor CXCR4 and thereby inhibits CXCL12 chemokine-induced migration.
    Masztalerz A; Zeelenberg IS; Wijnands YM; de Bruijn R; Drager AM; Janssen H; Roos E
    J Cell Sci; 2007 Jan; 120(Pt 2):219-28. PubMed ID: 17179206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in membrane sphingolipid composition modulate dynamics and adhesion of integrin nanoclusters.
    Eich C; Manzo C; de Keijzer S; Bakker GJ; Reinieren-Beeren I; García-Parajo MF; Cambi A
    Sci Rep; 2016 Feb; 6():20693. PubMed ID: 26869100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CXCL12/CXCR4 promotes proliferation, migration, and invasion of adamantinomatous craniopharyngiomas via PI3K/AKT signal pathway.
    Yin X; Liu Z; Zhu P; Wang Y; Ren Q; Chen H; Xu J
    J Cell Biochem; 2019 Jun; 120(6):9724-9736. PubMed ID: 30582214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulatory effects of trophoblast-secreted CXCL12 on the migration and invasion of human first-trimester decidual epithelial cells are mediated by CXCR4 rather than CXCR7.
    Zheng J; Wang H; Zhou W
    Reprod Biol Endocrinol; 2018 Mar; 16(1):17. PubMed ID: 29499763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisome proliferator‑activated receptor γ agonist rosiglitazone inhibits migration and invasion of prostate cancer cells through inhibition of the CXCR4/CXCL12 axis.
    Qin L; Gong C; Chen AM; Guo FJ; Xu F; Ren Y; Liao H
    Mol Med Rep; 2014 Aug; 10(2):695-700. PubMed ID: 24842333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparan sulfate differentially controls CXCL12α- and CXCL12γ-mediated cell migration through differential presentation to their receptor CXCR4.
    Connell BJ; Sadir R; Baleux F; Laguri C; Kleman JP; Luo L; Arenzana-Seisdedos F; Lortat-Jacob H
    Sci Signal; 2016 Nov; 9(452):ra107. PubMed ID: 27803285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.